Effects of anti-inflammatory [1, 2, 4]triazolo[4, 3-a] [1, 8]naphthyridine derivatives on human stimulated PMN and endothelial cells: an in vitro study.
BACKGROUND
124 triazolo [4, 3-a]18naphthyridine derivatives (including NF161 and NF177) were tested for anti-inflammatory, analgesic and antipyretic properties and for their effects on spontaneous locomotor activity in mice and acute gastrolesivity in rats. Both NF161 and NF177 appeared to be anti-inflammatory and analgesic agents without toxic effects or acute gastrolesivity, but NF161 showed stronger anti-inflammatory activity, whereas NF177 was more active as analgesic.


METHODS
An EIA kit was used to investigate the ability of NF161 and NF177 to affect prostaglandin E2 (PGE2) and prostacyclin (PGI2) production by human umbilical vascular endothelial cells (HUVEC). The compounds' effects on the production of reactive oxygen species (ROS) by human polymorphonuclear cells (PMNs) were studied in an in vitro cell model, evaluating inhibition of superoxide anion (O2-*) production induced by N-formylmethionyl-leucyl-phenylalanine (FMLP). Their effects on PMN adhesion to HUVEC were also investigated; they were incubated with PMNs and endothelial cells (EC) and challenged by stimuli including Platelet Activating Factor (PAF), FMLP, Phorbol Myristate Acetate (PMA), Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-1beta (IL-1beta). Adhesion was quantitated by computerized micro-imaging fluorescence analysis.


RESULTS
Neither compounds modified PGE2 or PGI2 production induced by IL-1alpha. O2-* production and myeloperoxidase release from PMNs stimulated by FMLP was inhibited in a dose- but not time-dependent manner by both 18naphthyridine derivatives, NF161 being statistically more active than NF177 (P < 0.01). The compounds inhibited adhesion evoked by the pro-inflammatory stimuli PAF, FMLP, TNF-alpha and IL-1beta in a concentration-dependent manner in the 10(-6)-10(-4)M range, being more active when PAF was used as stimulus and inactive when cells were challenged by PMA. Both compounds acted both on PMN and HUVEC.


CONCLUSIONS
Considering the interesting anti-inflammatory effects of these compounds in in vivo models and the absence of acute gastrolesivity, the study improved knowledge of anti-inflammatory properties of NF161 and NF177, also demonstrating their potential in vitro, through inhibition of O2-* production, myeloperoxidase release and PMN adhesion to HUVEC. Negative results on PG production suggest a cyclooxygenase (COX)-independent mechanism.
Dianzani
Chiara
C
Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, V P Giuria 9, 10125 Torino, Italy.
Collino
Massimo
M
Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, V P Giuria 9, 10125 Torino, Italy.
Gallicchio
Margherita
M
Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, V P Giuria 9, 10125 Torino, Italy.
Di Braccio
Mario
M
Department of Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV 3, 16132 Genoa, Italy.
Roma
Giorgio
G
Department of Pharmaceutical Sciences, University of Genoa, Viale Benedetto XV 3, 16132 Genoa, Italy.
Fantozzi
Roberto
R
Department of Anatomy, Pharmacology and Forensic Medicine, University of Turin, V P Giuria 9, 10125 Torino, Italy.